Omni Corneal Cross Linking System

Corneal Cross Linking Device

Corneal Cross Linking is a treatment whose goal is to strengthen the corneal stromal tissue through the formation of new chemical bonds between stromal collagen fibrils.

SCHEDULE A DEMO LEARN MORE

What is OMNI Cross Linking System

The OMNI Cross Linking System is designed for effective, safe, and user-friendly corneal treatment. It allows precise energy control from 3–45 mW/cm² with automatic timing and supports pulsed radiation for treating infectious keratitis. The built-in infrared camera tracks eye position to maintain proper distance, pausing treatment if movement occurs. It features calibration verification, optional pachymetry with Riboflavin selection, and easy data export via Wi-Fi, Bluetooth, or printer. A 7-inch color touchscreen displays real-time eye monitoring, treatment settings, and remaining time.

GET MORE INFO

PalmScan OMNI Corneal

Cross Linking System

The OMNI Cross Linking System was designed with a special focus on effectiveness, safety and user friendliness incorporating the latest clinical experiances.

Background

Corneal collagen cross-linking is a treatment that uses UV light and a photosensitizer, typically riboflavin, to strengthen the cornea by forming new chemical bonds between collagen fibers. Its main purpose is to stop the progression of ectasia—irregular thinning and bulging of the cornea—that can occur in conditions such as keratoconus or after vision correction surgeries like LASIK. By stabilizing the corneal structure, it helps maintain vision and prevent further distortion.

The procedure works through a process called photopolymerization, in which UV-activated riboflavin generates reactive oxygen molecules that create cross-links between collagen fibers. These bonds increase corneal stiffness and durability, primarily within the anterior stroma, improving corneal strength and long-term stability.

Clinical Experience

Multiple major clinical studies have demonstrated the effectiveness and safety of corneal cross-linking. More than 85% of eyes treated with the procedure show a significant improvement in best-corrected visual acuity (BCVA). Six months after treatment, reductions in corneal cylinder were observed in most patients, confirming the stability and efficacy of the technique.

GET MORE INFO

Testimonials

“

“It’s the best investment I've ever made. It's a simple unit, it's easy to use — I can’t imagine going back to one of those big bulky things.”
Seema Nanda, ODFOCUS & NEO customer since 2020

“

“Accessibility is self-evident. Anybody in a wheelchair or any kind of physical disability can easily perform this test. We don’t have to move them anywhere, and it just works perfectly for that.”
Babak Kamkar, ODFOCUS & G2 customer since 2020

“

“With the number of functionalities in this new device that could really help us a lot, we're taking visual field testing to a new level.”
Inder Paul Singh, MDFOCUS & NEO customer since 2019

“

“It just gave the information automatically and it was accurate, reliable data. It was very easy to put it into the chart and feel like we got the information to do what we needed for the patient.”
Nancy Tanchel, MDA Scan, Pachy, & NEO customer since 2007

“

“Multiple types of tests that can be done on this one instrument is great. I want to reduce the number of pieces of equipment that I have now — reduce our footprint while increasing the quality.”
Mark Perry, ODNEO customer since 2021

“

“There’s always turnover, but within a week our newest tech mastered the device. With this device, it is so much more automated and helpful — they can learn it so fast.”
Rajesh Khanna, MDFOCUS & NEO customer since 2020